Navigation Links
PolyOne Announces Third Quarter 2011 Results

onciliation to Consolidated Statements of OperationsThree Months Ended
September 30, 2011Adjusted Three Months
Ended September 30, 2010$EPS$EPSNet income

.04SunBelt equity income, after tax

––(6.1)(0.07)Special items, after tax (Attachment 2)

3.10.0321.80.23Tax adjustments (a)

(0.3)–3.60.04Adjusted net income / EPS

.24Reconciliation to Consolidated Statements of OperationsNine Months Ended

September 30, 2011Adjusted Nine Months
Ended September 30, 2010$EPS$EPSNet income

.76SunBelt equity income, after tax

(3.7)(0.04)(11.1)(0.11)Special items, after-tax (Attachment 2)

(75.8)(0.80)12.50.13Tax adjustments (a)

(1.4)(0.02)(13.0)(0.14)Adjusted net income / EPS

.64(a)  Tax adjustments include the net tax loss (benefit) from one-time foreign and domestic income tax items and deferred income tax valuation allowance adjustments on deferred tax assets.Attachment 2PolyOne Corporation and SubsidiariesConsolidated Statements of Operations (Unaudited)(In millions, except per share data)Special items (1):Three Months Ended

September 30,Nine Months Ended
September 30,2011201020112010Cost of salesEmployee separation and plant phaseout costs

$  (0.6)$  (0.8)$
(1.1)$  (1.0)Insurance reimbursements

1.3–3.219.1Environmental remediation costs

(4.8)(3.9)(7.9)(10.2)Acquisition related costs

––(0.1)–Impact on cost of sales

(4.1)(4.7)(5.9)7.9Selling and administrativeEmployee separation and plant phaseout costs


–(0.3)–1.9Acquisition related costs

(0.3)–(2.0)–Impact on selling and administrative

(0.8)(0.8)(2.7)1.1Gain on sale of investment in SunBelt


SOURCE PolyOne Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PolyOne GLS Selected as Healthcare Industry Marketing Specialist for Santoprene™ TPV Medical Grades
2. PolyOne Announces Sale of SunBelt Investment
3. PolyOne Features Non-Lead Radiation Protection at Medical Design and Manufacturing East Exhibition
4. PolyOnes Healthcare Solutions and Distribution Network Showcased at Medtec China
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
(Date:10/8/2015)... Calif. , Oct. 8, 2015  Ardelyx, ... company focused on gastrointestinal and cardio-renal diseases, today ... product candidate, tenapanor, will be presented at the ... presented findings will include measures of sustained response ... double blind, placebo-controlled, randomized Phase 2 trial. The ...
(Date:10/8/2015)... 8, 2015  Following months of investigation, Ross Feller ... nation alleging that the anticoagulant Xarelto,s recommended dosage doesn,t work ... Philadelphia on behalf of a ... because the drug didn,t work as the manufacturer suggested. ... suits shortly on behalf of clients from across the country ...
(Date:10/8/2015)... DUBLIN , Oct. 08 2015 /PRNewswire/ ... announced the addition of the "Natural ... Life Sciences Industry by Type (Rule-Based, Statistical, ... Europe, Asia-Pacific, Middle East and Africa, Latin ... report to their offering. --> ...
Breaking Medicine Technology:
... CrystalGenomics, Inc., a biopharmaceutical company with 3 clinical ... Study Report (CSR) from CG400549,s Phase I Multiple Ascending ... CG400549 is a potential first-in-class antibiotic candidate targeting the ... generating bacterial membrane and has a novel chemical structure ...
... Dynatronics Corporation (Nasdaq: DYNT ) plans to release ... the morning of Monday, May 16, 2011.   ... day at 1:00 p.m. ET to discuss its results for ... and use access code: 5687000. Dynatronics manufactures, markets ...
Cached Medicine Technology:
(Date:10/9/2015)... Stockholm, Sweden (PRWEB) , ... October 09, 2015 , ... ... 2015 Arnold Schwarzenegger World Jump Rope Championship in Madrid, Spain. Representing both the USA ... Speed Sprints, One-Minute Double Unders and One-Minute Am Front Crosses, she was awarded 1 ...
(Date:10/9/2015)... ... October 09, 2015 , ... ... “Agents of Change” program, a community improvement initiative that involves working with a ... benefit from the assistance of Confidence Plus Insurance is the Gleason Park Electric ...
(Date:10/9/2015)... ... 09, 2015 , ... "As a nurse, I care for male patients who ... to wear large diapers or pads. We came up with this as a better ... urine leaking from the tip of the penis. This prevents stains from forming on ...
(Date:10/9/2015)... ... October 09, 2015 , ... MMJ PhytoTech Limited ... Ed Begley Jr., airing 1st QT 2016 via the Discovery Channel. Dates and ... Phytotech Limited (MMJ) – a global leader in the field of commercializing medicinal ...
(Date:10/9/2015)... Nashville, TN (PRWEB) , ... October 09, 2015 , ... ... to announce their partnership as MD Anderson prepares to go-live on the Epic platform ... effort planned for early 2016. Santa Rosa will execute the contract by supporting Scheduling ...
Breaking Medicine News(10 mins):
... Smith brings free, national weight-loss initiative to Big Easy; Urges residents to ... ... Church, NEW ORLEANS, Nov. 21 Dr. ... to take control of their,health and give up the pounds to fight the ...
... 21 Flagship Global Health,Inc. ("Flagship") (OTC Bulletin Board: ... Chief Executive Officer. Co-founder Fred Nazem,remains Chairman of the ... and joined the specialty healthcare advocacy company in 2004. ... while Mr. Nazem will,focus on the strategic direction of ...
... are by nature sedentary , WEDNESDAY, Nov. 21 (HealthDay News) ... active is just a normal part of aging, but a ... , The program led to a 24 percent increase (about ... each week, according to the leaders of a University of ...
... dexamethasone improved outcomes, studies found , , WEDNESDAY, Nov. 21 ... a derivative of thalidomide extended survival, as well as ... in patients with multiple myeloma. , The combination of ... Drug Administration regulatory approval in June of 2006 for ...
... What would you do if you,suddenly found yourself unable ... wasn,t a drinker, exercised and got an adequate amount ... he suffered a stroke. In his new,book, "My Glitch: ... AuthorHouse -- ), Beel shares his,experiences of ...
... Conn., Nov. 21 Therap Services will host ... 5-7, 2007 in,Southbury, Connecticut. The 2nd Direct Support ... Support Professionals who are daily,users of Therap as ... Therap,s users and its developers and support staff., ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: